Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedigusMDGSW 12 Days Payable is 171.04 as of Dec. 2024, which is 55% above its 10-year median of 110.27. GuruFocus rates MDGSW with a GF Score™ of 12/100. The stock has 6 warning signs investors should review.
Medigus's average Accounts Payable for the
six
months ended in Dec. 2024 was $7.53 Mil. Medigus's Cost of Goods Sold for the
six
months ended in Dec. 2024 was $8.03 Mil.
Hence, Medigus's Days Payable for the
six
months ended in Dec. 2024 was 171.04.
The historical rank and industry rank for Medigus's Days Payable or its related term are showing as below:
MDGSW'
s Days Payable Range Over the Past 10 Years
Min: 28.9 Med: 110.27 Max: 751.78
Current: 148.58
During the past 13 years, Medigus's highest Days Payable was 751.78. The lowest was 28.90. And the median was 110.27.
MDGSW's Days Payable is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 68.41
vs MDGSW: 148.58
Medigus's Days Payable
increased
from Dec. 2023 (83.72) to Dec. 2024 (171.04).
It may suggest that Medigusdelayed paying its suppliers.
The historical data trend for Medigus's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDGSW vs RMSL, HSDT, ALRTF: Days Payable Comparison
For the Medical Devices subindustry, Medigus's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medigus Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medigus's Days Payable distribution charts can be found below:
* The bar in red indicates where Medigus's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medigus's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medigus (MDGSW) has a Days Payable of 171.04 as of Dec. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medigus and its competitors. This is 55% above median its historical median of 110.27. Over the past decade, Medigus' Days Payable has ranged from 28.90 to 751.78.
Is Medigus' Days Payable too high?
Medigus' current Days Payable of 171.04 is 55% above median its 10-year median of 110.27. Over the past 10 years, this metric has ranged from a low of 28.90 to a high of 751.78. The Medical Devices & Instruments industry median Days Payable is 68.41. Medigus' value of 171.04 is 150% above this industry median. Overall, Medigus has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medigus' Days Payable compare to RMSL and HSDT?
Medigus' Days Payable of 171.04 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 68.41. Medigus' value of 171.04 is 150% above this benchmark. Historically, Medigus' own Days Payable has ranged from 28.90 to 751.78 over the past decade. While the company's 10-year median is 110.27 vs. the industry median of 68.41, Medigus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.41, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medigus's current Days Payable of 171.04 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medigus and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medigus's current Days Payable is 171.04, which is 55% above median its own 10-year median of 110.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigus stock overvalued right now?
Medigus (MDGSW) has a current Days Payable of 171.04. The current Days Payable is 171.04, which is 55% above median its 10-year median of 110.27 and 150% above the Medical Devices & Instruments industry median of 68.41. Medigus' overall GF Score™ is 12/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medigus (MDGSW), the current Days Payable is 171.04 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.
12GF Score
Get the complete analysis for MDGSW
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDGSW has been successfully added to your 
